Epithalon is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Human studies (ages 60-80) showed significant telomere lengthening in blood cells. A prospective 6-year cohort study of 266 elderly subjects demonstrated 1.6-1.8 fold reduction in mortality with the parent compound Epithalamin. Multiple human studies completed. Epithalon is not fda-approved in usa. approved in russia and some eastern european countries as anti-aging pharmaceutical.
What Does the Research Say About Epithalon?
Human studies (ages 60-80) showed significant telomere lengthening in blood cells. A prospective 6-year cohort study of 266 elderly subjects demonstrated 1.6-1.8 fold reduction in mortality with the parent compound Epithalamin. Multiple human studies completed.
Epithalon (Tetrapeptide Ala-Glu-Asp-Gly (AEDG)) is a Geroprotective peptide, telomerase activator. Research interest has focused on its potential effects on telomere lengthening, anti-aging effects, improved immune function, melatonin regulation, oxidative stress reduction, cellular rejuvenation.
What Is the Evidence for Epithalon's Mechanism?
Interacts with specific DNA sequences (ATTTC) in the telomerase gene promoter, upregulating telomerase expression and activity in somatic cells. Enhances melatonin synthesis and modulation. Influences interleukin-2 mRNA expression and T-cell mitogenic activity. Also exhibits antioxidant and antimutagenic properties.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for Epithalon?
Human studies (ages 60-80) showed significant telomere lengthening in blood cells. A prospective 6-year cohort study of 266 elderly subjects demonstrated 1.6-1.8 fold reduction in mortality with the parent compound Epithalamin. Multiple human studies completed.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Epithalon has shown preliminary results.
What Does the Safety Research Show?
Excellent safety profile across clinical studies. Minimal reported adverse effects. Well-tolerated at established doses.
Epithalon is not fda-approved in usa. approved in russia and some eastern european countries as anti-aging pharmaceutical.
What Makes Epithalon Unique in Research?
The only clinically proven telomerase activator with documented human telomere lengthening AND a 1.6x mortality reduction in a 6-year prospective study — the strongest longevity data of any peptide.
This differentiator is important because it means Epithalon fills a role that other compounds in its class may not fully replicate.
Bottom Line on Epithalon Research
The evidence base for Epithalon is growing. Key research areas include telomere lengthening, anti-aging effects, improved immune function, melatonin regulation, oxidative stress reduction, cellular rejuvenation.
Stay current with PubMed searches for Epithalon for the latest publications.
Complete Guide
Epithalon (Epitalon): Longevity Peptide Research
Related Reading
- Epithalon Dosage Guide
- Epithalon Benefits
- Epithalon Side Effects
- Epithalon Stacking Guide
- Epithalon Cycle Guide
- MOTS-C Complete Guide
Calculate Your Epithalon Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Epithalon.
Open Calculator →Research-Grade Sourcing
If you're going to research Epithalon, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Epithalon?
Epithalon (Tetrapeptide Ala-Glu-Asp-Gly (AEDG)) is a Geroprotective peptide, telomerase activator. Synthesized based on the amino acid composition of bovine pineal extract (Epithalamin), designed to activate telomerase. It is researched for telomere lengthening, anti-aging effects, improved immune function, melatonin regulation, oxidative stress reduction, cellular rejuvenation.
What is the recommended Epithalon dosage?
Common dosages: 5-10 mg daily administered once daily for 10-20 day cycles via subcutaneous injection or intranasal. Cycle length: 10-20 days, repeated 2-3 times per year. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Epithalon?
Excellent safety profile across clinical studies. Minimal reported adverse effects. Well-tolerated at established doses.
Is Epithalon safe?
Epithalon has shown a favorable safety profile in research. Not FDA-approved in USA. Approved in Russia and some Eastern European countries as anti-aging pharmaceutical. All research should follow appropriate safety protocols.